Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DRUG FOR PROPHYLAXIS OR TREATMENT OF MUSCLE DAMAGE
Document Type and Number:
WIPO Patent Application WO/2017/131169
Kind Code:
A1
Abstract:
[Problem] The purpose of the invention is to provide a drug useful in the prophylaxis or treatment of muscle damage. [Solution] The invention relates to a novel pharmaceutical use of an extract from inflamed tissue inoculated with vaccinia virus, and relates to a drug for the prophylaxis or treatment of muscle damage comprising said extract as an active ingredient. This drug for the prophylaxis or treatment of muscle damage including said extract as an active ingredient is extremely useful as a drug having a high level of safety and efficacy.

Inventors:
INAGE KAZUHIDE (JP)
TAKAHASHI KAZUHISA (JP)
OHTORI SEIJI (JP)
ORITA SUMIHISA (JP)
Application Number:
PCT/JP2017/002973
Publication Date:
August 03, 2017
Filing Date:
January 27, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NAT UNIV CORP CHIBA UNIV (JP)
NIPPON ZOKI PHARMACEUTICAL CO (JP)
International Classes:
A61K35/36; A61K35/76; A61P21/00
Domestic Patent References:
WO2014057995A12014-04-17
WO2010131712A12010-11-18
Other References:
YUKO NAITO ET AL.: "Lack of Neu5Gc Expression Contributes to the Severity of Duchenne Muscular Dystrophy in Humans", TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, vol. 23, no. 132, 2011, pages 194 - 196, XP055535405, Retrieved from the Internet
Attorney, Agent or Firm:
HANABUSA PATENT & TRADEMARK OFFICE (JP)
Download PDF: